The antimicrobial activity of bupivacaine and pethidine in concentrations commonly used in epidural practice was studied by an agar dilution method against ten common micro-organisms. Both drugs showed increasing microbe inhibition with increasing drug concentrations. Bupivacaine at common epidural concentrations inhibited eight of the ten organisms and pethidine inhibited six. These findings confirm previous reports of microbe inhibition by bupivacaine, and in addition demonstrate a similar but slightly lesser activity by pethidine. Although antimicrobial activity of epidural drugs can be regarded as a desirable property, clinical implications of such findings remain unclear.
Local anaesthetic agents, in concentrations commonly used epidurally, are known to possess bacteriostatic and bacteriocidal properties against a broad range of microorganisms. [1] [2] [3] [4] More recently drugs belonging to the opioid class have also become established in pain management via the epidural route. Opioids possess a more complex and varied chemical structure than local anaesthetics, and whether they possess antimicrobial activity has received little attention. Rosenberg and Renkonen compared the antimicrobial activity of bupivacaine with morphine and found that morphine at 2 mg/ml, a concentration commonly used epidurally, had no influence upon micro-organism growth. 4 In this hospital, epidural pethidine (5 mg/ml) is commonly used on a patient-demand basis to provide postoperative analgesia following caesarean section. The preparation used (David Bull Laboratories, Melbourne) contains pethidine 50 mg in 10 ml saline, and is preservative-free. This paper compares the antimicrobial activity of pethidine with bupivacaine using the method of Rosenberg and Renkonen. 4 MATERIALS AND METHODS
Organisms and inocula
In an attempt to assess drug activity against flora commonly colonising skin, the following micro-organisms were tested: Escherichia coli (ATCC 25922); Pseudomonas aeruginosa (ATCC 27853); Staphylococcus aureus (ATCC 25923); Staphylococcus epidermidis (sensitive strain A TCC 12228); Streptococcus pyogenes (A TCC 19615); Streptococcus faecalis (A TCC 19433); and one each of clinical isolates of S. epidermidis (resistant strain); Candida albicans; and a multiple antibiotic-resistant S. aureus (MRSA). A clinical isolate of Streptococcus pneumoniae was also included. All organisms were inoculated into supplemented brain heart infusion broth (BHI) (except S. pneumoniae -inoculated into BH! containing 100/0 horse serum) and incubated overnight at 35 QC. All broths were then reinoculated into a second broth tube and incubated at 35 QC for six hours to bring the organisms into logarithmic growth. All suspensions were then adjusted with saline to give approximately 10 8 organisms/m!. A Steers replicator was used to deliver about 10 5 colonyforming units (CFU) per inoculum. The agar medium was Mueller-Hinton agar supplemented with 5OJo horse blood. The inoculated plates were examined after eighteen hours at 35 QC and compared with growth on a drug-free control plate. The result was scored as negative if there were less than ten colonies (99.99% inhibition) or a light haze at the inoculum site. This concentration was termed the minimal inhibitory concentration (MIC).
Drug concentrations
Bupivacaine hydrochloride pure powder (Astra Pharmaceuticals, Sydney) was dissolved in sterile saline in the ratio 1 :30 w /v, diluted and added to molten agar to give final plate concentrations of 5, 2.5, 1.25 and 0.5 mg/m!. Pethidine hydrochloride pure powder was obtained under signature from the Flinders Medical Centre Pharmacy Department and dissolved in sterile saline in a ratio of 1:3 w/v and diluted as above to give final plate concentrations of 50,25, 12.5,5.0,2.5,1.5 and 0.5 mg/m!. Table 1 tabulates the MIC of each drug to each organism. Bupivacaine demonstrated a concentrationdependent inhibition of microbial growth in eight of the ten organisms tested. Minimal inhibitory concentrations to these eight were within the range 2.5-5.0 mg/m!. Bupivacaine was ineffective against P. aeruginosa and C. albicans.
RESULTS
Pethidine had a similar but lesser degree of antimicrobial activity. At the concentration 5 mg/ml, pethidine inhibited six of the ten organisms. Resistent organisms were P. aeruginosa, S. aureus and C. albicans to which pethidine was effective only at two and one half times epidural concentrations, and S. faecalis, which was inhibited at a concentration five times that used epidurally.
DISCUSSION
Antimicrobial activity of local anaesthetic drugs was first suggested by J onnesco in 1909 5 and has been confirmed by several investigators. [1] [2] [3] [4] The results of our study with bupivacaine are in accord with those of Rosenberg and Renkonen. 4 Thus, at the standard epidural concentrations of 2.5-5.0 mg/ml, bupivacaine inhibited all micro-organisms tested with the exception of P. aeruginosa and C. albicans. The difference with regard to our finding of a higher MIC to C. albicans may not be significant as our results indicate that the MIC to our strain would not be far above 5.0 mg/m!.
We have now shown in this study that pethidine at epidural concentrations also inhibits the growth of micro-organisms, although to a somewhat lesser degree than bupivacaine. This antimicrobial activity of pethidine is in contrast to that of morphine which, in a previous study,4 showed no antibacterial activity in concentrations employed epidurally (0.2-2.0 mg/m!).
The mechanism of antimicrobial activity is not clearly understood. In the case of local anaesthetics, Gram negative bacteria are particularly sensitive to lignocaine and procaine 2 and both of these agents also cause loss of viability of Escherichia coli. Pseudomonas aeruginosa is the only Gram negative organism resistant to lignocaine 2 and bupivacaine. 4 Lignocaine has been shown to inhibit intracellular incorporation of radioactive precursors of DNA, RNA and proteins,2 and it has been postulated that the antimicrobial activity of local anaesthetics is secondary to changes in permeability of the cell wall or inhibition in the synthesis of cell membrane precursors.
In the case of opioids, it may be relevant that pethidine, unlike morphine, also has local anaesthetic properties and was in fact originally called 'isonipecaine'. These local anaesthetic effects were first reported by Way in 1946. 6 The antimicrobial properties of pethidine may therefore be related to its local anaesthetic effects upon the cell wall, although further tests with a larger range of organisms (particularly Gram negative) would be needed to confirm this hypothesis.
The clinical importance of these findings remains uncertain. Reports of infection following repeated epidural injection via a catheter have been extremely rare 7 and it is impossible to determine whether antimicrobial activity of the commonly used agents has contributed to this low incidence, or not. The concentrations of drugs achieved in the epidural space may, furthermore, be quite different to those injected and studied here due to such factors as diffusion and dilution by body fluids. Nevertheless, epidural abscess has been reported following epidural morphine 8 (which has no antimicrobial properties) whereas, to our knowledge, there have been no case reports of localised infection following epidural pethidine. Antimicrobial activity may therefore be regarded as a desirable property of agents which are administered intermittently or continuously via an epidural catheter.
